{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:21:05Z","timestamp":1783779665308,"version":"3.55.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to evaluate the association of vitamin D deficiency (VDD) and major adverse kidney events (MAKEs) among patients with chronic kidney disease (CKD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study using the TriNetX Global Collaborative Network. Eligible participants were adults with CKD who had a vitamin D testing between January 01, 2010 and January 31, 2025. According to the status of vitamin level, individuals were classified into two groups, VDD group and control group. Propensity score matching (PSM) was applied to balance baseline characteristics between groups. The primary outcome was the risk of MAKEs during one-year follow-up, while secondary outcomes included all-cause mortality and all-cause hospitalization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After PSM, 29,654 patients were included in each group. The VDD group was associated with a higher risk of MAKEs (hazard ratio [HR], 2.24; 95% confidence interval [CI], 2.08\u20132.41; <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.001). Stratified analyses revealed consistent relationship across multiple subgroups. Additionally, the VDD group was also associated with higher risks of all-cause mortality (HR, 1.92; 95% CI, 1.82\u20132.02; <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.001), and all-cause hospitalization (1.19; 95% CI, 1.14\u20131.25; <jats:italic>p<\/jats:italic> &amp;lt;\u202f0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>VDD in patients with CKD is associated with a significantly higher risk of MAKEs. The finding suggests that VDD may contribute to worse adverse kidney events and highlight the importance of vitamin D status in the clinical management.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1650514","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:13:12Z","timestamp":1759810392000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Major adverse kidney events among chronic kidney disease patients with vitamin D deficiency"],"prefix":"10.3389","volume":"12","author":[{"given":"Yu-Min","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Li","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chuan","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jheng-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Lun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"ref1","first-page":"S5-8","article-title":"Vitamin D and chronic kidney disease","volume":"19","author":"Williams","year":"2009","journal-title":"Ethn Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/bonekey.2013.232","article-title":"Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD)","volume":"3","author":"Nigwekar","year":"2014","journal-title":"Bonekey Rep"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/nu5010111","article-title":"Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation","volume":"5","author":"Wacker","year":"2013","journal-title":"Nutrients"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"868961","DOI":"10.1155\/2015\/868961","article-title":"Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease","volume":"2015","author":"Obi","year":"2015","journal-title":"Dis Markers"},{"key":"ref6","author":"Jover-R\u00edos","year":"2019"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3390\/nu14153009","article-title":"Vitamin D and secondary hyperparathyroidism in chronic kidney disease: a critical appraisal of the past, present, and the future","volume":"14","author":"Brandenburg","year":"2022","journal-title":"Nutrients"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/life14050617","article-title":"Vitamin D: a bridge between kidney and heart","volume":"14","author":"Secondulfo","year":"2024","journal-title":"Life (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.34067\/KID.0003552020","article-title":"Kidney biomarkers and major adverse kidney events in critically ill patients","volume":"2","author":"Flannery","year":"2021","journal-title":"Kidney360"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1210\/jc.2017-00105","article-title":"Vitamin D status and all-cause mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis","volume":"102","author":"Jayedi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jvs.2014.01.037","article-title":"Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease","volume":"60","author":"Walker","year":"2014","journal-title":"J Vasc Surg"},{"key":"ref12","year":"2025"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1540633","DOI":"10.3389\/fnut.2025.1540633","article-title":"Association between vitamin D deficiency and major depression in patients with chronic kidney disease: a cohort study","volume":"12","author":"Chen","year":"2025","journal-title":"Front Nutr"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1236233","DOI":"10.3389\/fnut.2023.1236233","article-title":"Association of vitamin D deficiency with post-stroke depression: a retrospective cohort study from the TriNetX US collaborative networks","volume":"10","author":"Ho","year":"2023","journal-title":"Front Nutr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00394-023-03298-3","article-title":"Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection","volume":"63","author":"Wu","year":"2024","journal-title":"Eur J Nutr"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e71952","DOI":"10.7759\/cureus.71952","article-title":"Short-term outcomes in patients with coexistence of COVID-19 infection and vitamin D deficiency: a large cohort study","volume":"16","author":"Chan","year":"2024","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/pds.5083","article-title":"Time-related biases in pharmacoepidemiology","volume":"29","author":"Suissa","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/14787210.2024.2334052","article-title":"Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease","volume":"22","author":"Chen","year":"2024","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","author":"Palmer","year":"2015","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/biom15010039","article-title":"Comparative efficacy and safety of cardio-renoprotective pharmacological interventions in chronic kidney disease: an umbrella review of network meta-analyses and a multicriteria decision analysis","volume":"15","author":"Bellos","year":"2024","journal-title":"Biomolecules"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12933-024-02450-5","article-title":"Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study","volume":"23","author":"Garofolo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/27697061.2025.2461215","article-title":"Clinical outcomes in diabetic patients with zinc deficiency: a multi-institutional population-based study","volume":"44","author":"Wu","year":"2025","journal-title":"J Am Nutr Assoc"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1589907","DOI":"10.3389\/fnut.2025.1589907","article-title":"Mortality and cardiorenal outcomes among heart failure patients with zinc deficiency: a multicenter retrospective cohort study of 8,290 patients","volume":"12","author":"Lin","year":"2025","journal-title":"Front Nutr"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"ref27","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/ijerph15081773","article-title":"Vitamin D deficiency in chronic kidney disease: recent evidence and controversies","volume":"15","author":"Franca Gois","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1210\/jc.2018-01747","article-title":"Modifiers of plasma 25-Hydroxyvitamin D and chronic kidney disease outcomes in Black Americans: the Jackson heart study","volume":"104","author":"Lunyera","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"8975396","DOI":"10.1155\/2022\/8975396","article-title":"Association between vitamin D deficiency and levels of renin and angiotensin in essential hypertension","volume":"2022","author":"Han","year":"2022","journal-title":"Int J Clin Pract"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/HJH.0000000000001220","article-title":"The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial","volume":"35","author":"McMullan","year":"2017","journal-title":"J Hypertens"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ki.2013.355","article-title":"Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?","volume":"85","author":"Sarafidis","year":"2014","journal-title":"Kidney Int"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"13514","DOI":"10.3390\/cimb46120807","article-title":"The anti-inflammatory roles of vitamin D for improving human health","volume":"46","author":"Fenercioglu","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e10405","DOI":"10.1002\/jbm4.10405","article-title":"Vitamin D and immune regulation: antibacterial, antiviral, anti-inflammatory","volume":"5","author":"Lb","year":"2021","journal-title":"JBMR Plus"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/ijms21010263","article-title":"Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites","volume":"21","author":"Rapa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1681\/ASN.2012040383","article-title":"Vitamin D receptor signaling in podocytes protects against diabetic nephropathy","volume":"23","author":"Wang","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3265\/Nefrologia.pre2013.Apr.12025","article-title":"Vitamin D and proteinuria: a critical review of molecular bases and clinical experience","volume":"33","author":"P\u00e9rez-G\u00f3mez","year":"2013","journal-title":"Nefrologia"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3265\/Nefrologia.pre2013.Jul.12091","article-title":"The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder","volume":"33","author":"Diniz","year":"2013","journal-title":"Nefrologia"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MED.0000000000000294","article-title":"FGF-23 and cardiovascular disease: review of literature","volume":"23","author":"Batra","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/ki.2013.332","article-title":"Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of klotho deficiency","volume":"85","author":"Jimbo","year":"2014","journal-title":"Kidney Int"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/oxfordjournals.aje.a112408","article-title":"Bias due to misclassification in the estimation of relative risk","volume":"105","author":"Copeland","year":"1977","journal-title":"Am J Epidemiol"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1650514\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T04:13:13Z","timestamp":1759810393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1650514\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":47,"alternative-id":["10.3389\/fnut.2025.1650514"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1650514","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"article-number":"1650514"}}